Related Experiment Video
Updated: Jun 30, 2025
03:45
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
3.1K
Cardiomyopathies in Women
1Houston Methodist DeBakey Heart & Vascular Center, Houston, Texas, US.
Methodist Debakey Cardiovascular Journal
|March 18, 2024
Summary
Women with heart failure experience higher morbidity and unique challenges due to sex-specific physiology and underrepresentation in clinical trials. Addressing these gender differences is crucial for equitable advanced heart failure therapy outcomes.
Area of Science:
- Cardiology
- Cardiovascular Medicine
- Medical Research
Background:
- Heart failure impacts over 2.6 million in the US, with women facing higher morbidity despite better survival.
- Anatomical and physiological sex differences in the heart influence cardiac function in women.
- Women are underrepresented in clinical trials, leading to data extrapolation from male populations.
Purpose of the Study:
- To explore sex-specific differences in heart failure etiology, manifestation, and treatment outcomes in women.
- To highlight the impact of gender on cardiac physiology and disease progression.
- To identify potential solutions for balancing heart failure care between men and women.
Main Methods:
- Review of existing literature on sex differences in heart failure.
- Analysis of data regarding women's representation in clinical trials.
- Exploration of sex-specific factors in heart failure outcomes and advanced therapies.
Main Results:
- Women exhibit distinct heart failure etiologies and genetic cardiomyopathy manifestations.
- Sex-related differences significantly affect heart failure outcomes and access to advanced therapies.
- Underrepresentation in trials necessitates a deeper understanding of female-specific heart failure.
Conclusions:
- Acknowledging and addressing gender-specific differences in heart failure is essential for equitable care.
- Further research and inclusive clinical trial designs are needed to improve outcomes for women.
- Tailoring advanced heart failure therapies based on sex-specific factors can optimize treatment efficacy.
Related Concept Videos
01:26Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
01:28Mechanism of Cardiac Arrhythmias
919
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
919
01:29Pathophysiology of Cardiac Performance
645
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
645
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:24Disorders of the Female Reproductive System
357
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
357
01:26Heart Failure Drugs: Inotropic Agents
584
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
584